Jeffrey Zajac AO
University of Melbourne, VIC, Australia
Professor Jeffrey D Zajac is a clinical academic with research interests in both clinical endocrinology and molecular endocrinology. He has focussed on steroid and peptide hormone action and effects.
He has investigated:
The androgen receptor (AR) structure and function and the effect of mutations on human illness. He has done extensive studies on testosterone and men's health.
Calcium regulating hormones, parathyroid hormone, PTHrP, and calcitonin.
He was part of the team which first isolated PTHrP and has investigated the physiological role of the calcitonin receptor.
Type 2 diabetes looking at glucose toxicity
Transgender animal models and transgender health
He trained at the University of Melbourne for his undergraduate degree and PhD and had a postdoctoral appointment at the Massachusetts General Hospital in the Harvard Health system.
During his career he was Head of the Department of Medicine (University of Melbourne) as well as Head of the Department of Medicine, (University of Melbourne) at Austin Health. He was also director of the Department of General Medicine and Director of the Department of Endocrinology.
He is now happily retired and pursuing interests in clinical endocrinology and endocrine research.
Presentations this author is a contributor to:
Initiating injectable therapy in hospital versus the home: experiences of people with type 2 diabetes and diabetes team providing care (#389)
2:00 PM
Rajna Ogrin
ADEA Poster Viewing Two
Prevalence of diabetes amongst patients hospitalised with decompensated heart failure and their outcomes (#8)
9:45 AM
Kaylyn Khoo
ADS Clinical Orals - Epidemiology & Cardiovascular Complications
The Prevalence of Diabetes Mellitus and its Association with Stroke Inpatient Outcomes (#7)
9:30 AM
Jeremy Lew
ADS Clinical Orals - Epidemiology & Cardiovascular Complications